Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.33 |
| ▸ | MAOB | P27338 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 2/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.31 |
| ▸ | PDE4A | P27815 | 2/20 | 0.30 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.30 |
| ▸ | PDE4B | Q07343 | 2/20 | 0.30 |
| ▸ | PDE4C | Q08493 | 2/20 | 0.30 |
| ▸ | PDE4D | Q08499 | 2/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8527189 | 0.77 | KDM4E (0.50) | KDM4EALDH1A1CYP1A2GAAAPOBEC3G | |
| SCHEMBL1555139 | 0.74 | CYP1A2 (0.38) | CYP1A2POLBL3MBTL1 | |
| Iodide SCHEMBL6324119 | 0.72 | CYP1A2 (0.37) | CYP1A2POLBL3MBTL1 | |
| SCHEMBL3520507 | 0.71 | — | — | |
| SCHEMBL30366081 | 0.71 | CYP1A2 (0.33) | CYP1A2POLBL3MBTL1 | |
| SCHEMBL23863066 | 0.69 | — | — | |
| SCHEMBL6496071 | 0.69 | ALDH1A1 (0.32) | ALDH1A1CYP1A2POLBL3MBTL1 | |
| SCHEMBL8604420 | 0.69 | KDM4E (0.41) | KDM4EALDH1A1CYP1A2POLBGAA | |
| SCHEMBL9204184 | 0.69 | — | — | |
| SCHEMBL8647302 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3010893-B1 | ARYLSULFIDE AND ARYLSULFOXIDE DERIVATIVES AS ACARICIDES AND INSECTICIDES | BAYER CROPSCIENCE AG (DE) | 2019-10-02 | — | — | EP | disclosed |
| US-9981940-B2 | Aryl sulfide derivatives and aryl sulfoxide derivatives as acaricides and insecticides | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2018-05-29 | — | — | US | disclosed |
| US-20160145235-A1 | ARYL SULFIDE DERIVATIVES AND ARYL SULFOXIDE DERIVATIVES AS ACARICIDES AND INSECTICIDES | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2016-05-26 | — | — | US | disclosed |
| US-5739349-A | CHEMICAL INTERMEDIATE FOR HERBICIDES, INSECTICIDES | BAYER AKTIENGESELLSCHAFT (DE) | 1998-04-14 | — | — | US | disclosed |
| EP-0661277-B1 | Process for making triazolines and new untermediates used therein | BAYER AG (DE) | 1998-03-11 | — | — | EP | disclosed |
| US-5688963-A | CHEMICAL INTERMEDIATES FOR PREPARATION OF HERBICIDES AND INSECTICIDES | BAYER AKTIENGESELLSCHAFT (DE) | 1997-11-18 | — | — | US | disclosed |
| EP-0657437-B1 | Process and novel intermediates for the preparation of triazolinones | BAYER AG (DE) | 1997-08-27 | — | — | EP | disclosed |
| US-5639891-A | HERBICIDES; INSECTICIDES | BAYER AKTIENGESELLSCHAFT (DE) | 1997-06-17 | — | — | US | disclosed |
| US-5508420-A | REACTING TRIAZOLINETHIONE WITH OXIDANT, REACTING FORMED TRIAZOLESULFONIC ACID WITH WATER TO FORM TRIAZOLINONE | BAYER AKTIENGESELLSCHAFT (DE) | 1996-04-16 | — | — | US | disclosed |
| US-5475115-A | Reacting sulfonyltriazole with alkali hydroxide followed by acidification | BAYER AKTIENGESELLSCHAFT (DE) | 1995-12-12 | — | — | US | disclosed |
| EP-0661277-A1 | Process for making triazolines and new untermediates used therein | BAYER AG (DE) | 1995-07-05 | — | — | EP | disclosed |
| EP-0657437-A1 | Process and novel intermediates for the preparation of triazolinones | BAYER AG (DE) | 1995-06-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160145235-A1 | ARYL SULFIDE DERIVATIVES AND ARYL SULFOXIDE DERIVATIVES AS ACARICIDES AND INSECTICIDES | ARSA, SQOR, AHR | KDM4E 1804/4885ALDH1A1 100/4885CYP1A2 79/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.